| Study
Name |
#
of Pts |
Evaluated |
| Subpectoral
Implantation of ICD |
8
|
A
study to determine the safety and efficacy of a nonepicardial
ICD using transvenous lead & submuscular patch in patients with
life threatening arrthythmias |
| MUSTT |
32 |
Multicenter
Unsustained Tachycardia Trial |
| IV
Amiodarone |
5 |
An
open label safety study of Intravenous Amiodarone HCI in pts with
life threatening ventricular tachycardia/fibrillation |
| VIGOR
SR |
5
|
A
study of the safety and efficacy of the CPI single chamber VIGOR SR
pulse generator, models 1130 & 1135 & the associated software
module Model 2075 |
| Models
7217B & 7219E PCDs with Endotak 60 |
22
|
A
study of the safety and effectiveness of ENDOTAK 60 series lead system
(JEWEL) in detecting & treating VT & VF |
| Ventak
Prx III HC AICD |
3
|
A
study of the safety & efficacy of a Ventak PRx with the pulse
gererator can being an active electrode (hot can) vs non-active can
(cold can) |
|
Trilogy DR+ Models
2360L & 2364L |
18
|
A
study to evaluate the operation, safety & efficacy of the Trilogy
DR+ pulse generator in pts requiring dual chamber, rate responsive
pacemakers for bradycardia |
| Model
1242T & 1246T Endocardial Pacing Leads |
1
|
A
study of Pacesetter passive plus bipolar, endocardial pacing leads |
| Model
7218 ICD |
10
|
A
study of the safety & effectiveness of Medtronic Model SPI system
used in the detection & treatment of VT & VF |
| CPI
Pace/Sense Acute Study Device (PS-ASD) |
7
|
A
study of the pacing & sensing capabilities of PS-ASD devices |
| Trilogy
SR+ Models 2260L & 2264L |
3
|
A
study to evaluate the operation, safety and efficacy of the
Trilogy SR+ pulse generator in pts requiring an implanted, single
chamber, rate responsive pacemaker for bradycardia |
| Tendril
DX Endocardial lead |
56
|
A
study of the safety & efficacy of the Tendril DX model 1388T steriod
eluting screw in pacing lead |
| PURSUIT |
46 |
A
randomized, double blind evaluation of the efficacy & safety of
2 dosing regimens of Integrelin vs placebo for reducing mortality
& MI in pts with unstable angina or Non Q wave MI |
| Aegis
Model 2600 |
1
|
A
study of the safety and efficacy of the Aegis Model 2600 |
| OPUS
1 |
28
|
A
randomized, controlled trial to compare clinical restenois rates,
quality of life & costs in pts treated with "optimal"
PTCA with stent only when necessary vs routine stent use |
| Prophylaxis
w/Sotalol |
60
|
A
study to evaluate the efficacy of sotalol in preventing post operative
Afib/Aflutter in the cardiac surgery patient. It also accessed
the SAECG as a predictor. |
| Aplaud |
7 |
A
double blind placebo controlled study to access safety, tolerability,
pharmacokinetics & effect on platelet aggrefation of a dose range
of SB 214857 with aspirin in pts with MI, unstable angina, TIA or
stroke |
| REOMI |
6 |
A
study of the effect of Glycoprotien 11b/111a inhibition without thrombolytic
therapy on reperfusion in acute MI |
| High
Frequency Stimulation |
1 |
To
determine if high frequency stimulation induced cardioversion is possible
by prolonging the afib cycle lengths in pts w/persistent afib treated
w/propfanone. |
| Retavase |
2 |
A
study of prehospital use of the thrombolytic Retavase |
| Symphony |
8
|
A
phase III randomized double blind, aspirin controlled trial to evaluate
the efficacy & safety of sibrafiban, an oral platelet glycoprotein
11b/111a antagonist, as therapy for the prevention of secondary vascular
events in pts after acute coronary syndrome |
| Acute |
4
|
A
randomized trial to investigate a TEE guided approach to anti
coagulation management to decrease incidence of embolization after
cardioversion |
| Internal
Cardioversion |
5 |
A
study of intracardiac defibrillation in pts with afib who failed conventional
transthoracic cardioversion. |
| Trumpet |
5
|
A
phase IV study of the lipid changes in patients treated with Tricor |
| Cook
Balloon |
13 |
A
study of the new MBC balloon dilatation catheters. |
| BH88 |
59 |
To
test the Ensure diagnostic concept for predicting an individual's
cholesterol responsiveness to diet therapy. |
| Prince |
2 |
A
study of the effect of pravastatin on plasma levels of C reactive
protein (hs-CRP) in primary and secondary prevention. |
| Corinthian |
1 |
To
evaluate the safety and effectiveness of the Cordis Palmaz Corinthian
stent in iliac patients after suboptimal PTA. |
| EGM
Width |
12 |
A
evaluation of changes in EGM width over time and with changes in body
position. |
| 6944
ICD Lead |
28 |
A
phase I study of new Medtronic ICD lead. |
| Copernicus |
4 |
A
trial to determine the effect of carvedilol on mortality in patients
with severe chronic heart failure. |
| Ultra
Revive |
14 |
A
study of the ACS Multi Link Ultra coronary stent in pts with saphenous
graft & de novo native lesions. |
| Revive |
10 |
A
non randomized evaluation of the ACS Multi link duet coronary stent
system in saphenous vein grafts |
| Microny/Regency |
17 |
To
evaluate the safety and efficacy of the Microny SR+ & Regency
SR+ pacemakers when used in combination with Tendril DX or passive
plus DX leads |
| Cadillac |
44 |
To
compare clinical outcomes between the ACS RX Multilink stent to ptca
when used within 12 hours of acute MI. |
| Suport |
16 |
A
study to compare Scimed NIR stent vs ACS Multilink Duet. |
| Octave |
3 |
A
comparison of omapatrilat vs enalapril for hypertension |
| Bravo |
3 |
A
study to compare the incidence of clinical events in pts receiving
lotrafiban or placebo combined w/aspirin. |
| DTI-0009 |
17 |
Outpatient
intravenous drug fo treatment of narrow QRS complex tachycardia or
atrial fibrillation/flutter |
| Replace |
5 |
A
study of angiomax in percutaneous coronary intervention to reduce
clinical events. |
| MIST |
1 |
A
comparison of two stents in de novo or restenotic iliac arteries with
suboptimal PTA. |
| ICD
Septal Lead |
1 |
A
study to show if defibrillation thresholds can be reduced by placing
the RV coil along the interventricular septum |
| Open
Label Carvedilol |
1 |
A
open label study of Carvedilol in patients that participated in the
Copernicus study. |
| Adopt
A |
39 |
A
randomized trial to evaluate new pacemaker algorithm for over-drive
pacing for prevention of Afib. |
| OriginEP |
9 |
A
study to assess the practical feasibility of the noninvasive OriginEP
multi-electrode ECG mapping system in recording single beats. |
| RVA
vs RVOT |
3 |
A
comparison of exercise capacity in patients with pacing leads in the
right ventricular apex vs the right ventricular outflow tract. |
| WCD |
1 |
Study
of the safety and effectiveness of the Wearable Cardioverter Device
in transplant, complicated post MI and complicated coronary bypass
patients. |
| ASSURE |
1 |
To
diagnosis recurrent, unexplained syncope using the Reveal Plus ILR
compared with conventional strategies |
| Aspire2 |
12 |
To
evaluate the safety and efficacy of renal artery stenting compared
to balloon angioplasty alone. |
| TP
10 |
35 |
A
phase II study to address the negative effects of complement activation
during and following coronary artery bypass surgery |
| Astaxanthin |
101 |
Astaxanthin
supplementation and potential reduction of C-reactive protein levels. |
| A
Comet 1/A Star |
2 |
To
assess efficacy of daily oral azim2HCl vs placebo in treating or preventing
Afib |
| DTI0009
Phase 2 |
2 |
A
randomized, dose response trial of IV DTI-0009 for ventricular rate
control in adult patients with Afib |
|
CRAFT |
6 |
A
trial of the tolerance & efficacy of RSD1235 in patients with
recent onset Afib |
| Amiovirt |
4 |
A
randomized trial for patients with NSVT and non ischemic myopathy
randomized to amiodarone or ICD. |
| Credo |
7 |
A
double-blind randomized trial of clopidogrel & aspirin for the
prevention of vascular events and mortality in pts undergoing coronary
intervention. |
| RID-AF |
45 |
A
study to show reduced incidence & duration of AF/AT with the Jewel
AF Dual Chamber AMD. |
| TOVA |
11 |
Study
of ICD patients to gain insight into triggering of potentially lethal
arrthymias. |
| Amiodarone
Aqueous I.V. |
19 |
A
comparison of the incidence of hypotension with 2 formulations of
IV amiodarone: Cordarone IV vs Aqueous Amiodarone IV injection. |
| COMMA |
3 |
A
trial of two IV dosing regimens of h5G1.1-scFv in pts with acute MI
undergoing PTCA |
| IMPACT |
4 |
A
study of the impact of medical speciality on patiant compliance to
treatment |
| MedHall
Outcomes |
9 |
Influence
of prosthetic valve type and orientation on clinical and hemodynamic
outcome after aortic valve replacement. |
| CRUSADE |
49 |
A QI study of risk stratification of unstable angina to suppress adverse
outcomes with early implementation of ACC/AHA guidelines |
| Vascucoil |
27 |
To
clinical investigation of the Vascucoil self expanding peripheral
stent. |
| Valiant |
24 |
A
comparison of efficacy & safety of long term treatment with valsartan,
catopril & their combination in high risk patients after MI. |
| Soar |
6 |
A
non randomized, prospective, multi-center, consecutive registry of
sub-optimal renal angioplasty. |
| Navi
Star
Thermo Cool |
6 |
Evaluation
of the Navi Star Thermo Cool Catheter w/Stockert 70 radiofrequency
generator for endocardial ablation in pts w/a flutter |
| Charm |
3 |
Candesartan
in Heart Failure-Assessment of reduction in mortality and morbidity. |
| Natural
History of Afib |
25 |
A
prospective, randomized, parallel group, single blinded study of pts
w/Afib, no cardioversion and a need for a dual chamber pacemaker. |
| REPLACE2 |
31 |
A
study of angiomax in percutaneous coronary intervention to reduce
clinical events |
| PRIMO CABG |
18 |
A trial of pexelizumab on total mortality & Mi in pts undergoing CABG |
| Pride |
308 |
Effects
of Heart Disease Education on Older Women |
| SCDHeFT/T
Wave Alternans |
79/28 |
A
randomized study of effectiveness of Amiodarone (or placebo) vs. defibrillator
in reducing SCD in HF. |
| PROVE-IT |
4 |
A
double-blind, randomized trial for patients who have experienced an
acute coronary syndrome to compare two statin drugs and examine the
role of infection. |
| ABCD |
1 |
A
prospective multi center study to determine the effectiveness of TWA
in predicting VT events in pts with ischemic disease and NSVT. |
| Stamina
HFP |
25 |
A
study of Anemia in a Heart Failure Population |
| Definite |
7 |
Defibrillators
in non-ischemic cardiomyopathy treatment evaluation. |
| JUMBO |
5 |
A
study to evaluate a new oral antiplatelet agent in PCI with Stent |
| ENPULSE |
3 |
A
study to evaluate a new pacemaker feature |
| Sudden
Death Athletic Screen |
457 |
Can a hospital based screening program identify athletes at rick for sudden
cardiac death |
| SYNERGY |
18 |
A
trial to compare low molecular weight heparin, enoxaparin vs unfractionated
heparin in high risk patients with non ST elevation acute coronary
syndromes |
| ITI
Iliac Stent |
17 |
A
randomized trial of Intratherapeutic's iliac stent for iliac artery
occlusion/Suboptimal angioplasty. |
| ESSENTIAL |
4 |
A
trial of oral Enoximone vs placebo in advanced chronic heart failure
subjects |
| PREVENT
IV |
31 |
A
study to compare CGT003 (an E2F decoy) to placebo in pts undergoing
CABG to inhibit neointima formation to prevent accelerated aterhosclerosis
in vein grafts. |
| RESTORE |
10 |
To
demonstrate the ITI renal stent is safe & effective for treating
renovascular htn caused by renal artery stenosis or occlusion |
| PROTEGE |
3 |
A
trial of the protege self expanding nitinol stent in iliac artery
disease |
| RHYTHM |
42 |
A trial of resynchronization for hemodynamic treatment for Heart Failure
Management |
| SAFARI |
26 |
A trial to evaluate the safety & efficacy of the Selection Model 9000
application in pts who are currently indicated for a dual chamber
pacemaker |
| VIBRANT |
68 |
A registry for value of information based from pacemaker
recordings & new technology |
| VALOR |
3 |
A
study to evaluate contrast in coronary angiograms and interventions |
| TP10-002 |
6 |
A
study to of TP10 in women undergoing CABG |
| SPIDER |
9 |
A
study to evaluate a new distal protection device in PCI in SVG |
| ACT
I |
25 |
A
study to evaluate a new drug for atrial fib and atrial flutter |
| DIARY |
3 |
A
study of CHF events in patients with BI V ICDs |
| PREVENT
V |
3 |
A
study of E2F Decoy in hemodialysis grafts |
| PRIMO CABG II |
6 |
A
study of investigational drug vs placebo for patients undergoing CABG |
| ACT
III |
6 |
A
study to evaluate a new drug for atrial fib and atrial flutter |
| ACT
II |
2 |
A
study to evaluate a new drug for atrial fib and atrial flutter p cabg
and or valve |
| STELLAR |
15 |
A
registry of the Cypher stent |
| FUSION
II |
2 |
A
study comparing serial Natecor infusions to placebo in Class III &
IV CHF |
| NAPA |
1 |
A
study of Natecor in CABG |
| ASSESS
HF |
11 |
A
study of physican assessment of ICD home monitoring data |
| AWARE |
2 |
A
study of a new pacemaker AT/AF Detection Algorithm |
| GAMMA |
3 |
A
study to evaluate a new drug for ventricular tachycardia |
| AF
CHF |
2 |
To
compare therapeutic strategy to restore and maintain sinus rhythm
in patients with CHF and AF vs a strategy of rate control alone |
| OPTION |
11 |
A
study of the Tuplos Biotronik BI V ICD |
| HAT |
19 |
A trial of home AEDs vs CPR |
| VICTORY |
17 |
A
study of a new pacemaker |
| PROVE |
48 |
A
study of ICD programming for VT |
| PAIRED |
8 |
A
study of home monitoring of a pacemaker |
| LINK |
10 |
A
study of a new ICD lead |
| APL
Poly |
18 |
A
study of a new pacemaker lead |
| ACUITY |
19 |
A
study of Angiomax vs heparin in ACS |
| FSR |
5 |
A
study of a new pacemaker lead |
| RED
HF |
4
SF |
A
study of a drug for anemia in CHF |
| EZ
PATH |
3 |
A
study of exetimibe & statin in high risk patients |
| Protocol
24 |
1 |
A
study of naicin & statin |
| NAPA
3 |
1 |
A
study of a drug for acute peripheral artery occlusion |
| ACT
IV |
11 |
A
study of a new drug for Afib |
| RETHINQ |
10 |
A
study of narrow QRS in CRT Therapy |
| RESTORE
IT |
5,
23 SF |
A
study of an antibotic for carotid stenosis |
| Response
HF |
11 |
A
study of CRT Therapy w/V-V timing for BiV ICDs |
| Epic
II PAS |
3 |
A
study of patient notifier feature of ICD |
| Early
ACS |
11 |
A
study of eptifibatide in non ST elevation ACS |
| AVE S7 Stent Registry |
6 |
A post market study of Medtronic AVE S7 with discrete technology coronary
stent |